Reunion Neuroscience (TSE:REUN) Stock Price Up 4.4%

Reunion Neuroscience Inc. (TSE:REUNGet Rating) shares rose 4.4% on Wednesday . The stock traded as high as C$0.95 and last traded at C$0.95. Approximately 11,613 shares changed hands during trading, an increase of 44% from the average daily volume of 8,050 shares. The stock had previously closed at C$0.91.

Analyst Ratings Changes

Separately, Stifel Nicolaus lowered shares of Reunion Neuroscience from a “speculative buy” rating to a “hold” rating in a research report on Wednesday, March 15th.

Reunion Neuroscience Trading Up 4.4 %

The firm has a market capitalization of C$11.07 million, a P/E ratio of -0.15 and a beta of 4.23. The firm’s fifty day moving average price is C$1.00.

Reunion Neuroscience Company Profile

(Get Rating)

Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions.

Featured Stories

Receive News & Ratings for Reunion Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reunion Neuroscience and related companies with's FREE daily email newsletter.